Signaling Pathways - HCV Proteases - Insulin and Insulin-like Receptors - HIV - Cdc42
清除全部
-
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A8300 ZCL2781 CitationTarget: Cdc42Summary: Cdc42抑制剂 -
A5618 Daclatasvir (BMS-790052)中文名: 达卡他韦Target: HCV ProteasesSummary: HCV NS5A抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A3820 Simeprevir1 Citation中文名: 西咪匹韦Target: HCV ProteasesSummary: HCV NS3/4A蛋白酶抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A3237 Betulinic acid中文名: 白桦脂酸,桦木酸Target: Aminopeptidases|Topoisomerases|HIVSummary: 抗HIV和抗肿瘤化合物，五环三萜类化合物 -
A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂，有效的胰岛素敏化剂 -
A4024 Danoprevir (RG7227)中文名: 丹诺瑞韦Target: HCV ProteasesSummary: HCV NS3/4A蛋白酶抑制剂